TipRanks
Go Ultimate55% OFF

Nordson (ND1) AI Stock Analysis

DE:ND1

Nordson

(Frankfurt:ND1)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
High-quality cash generationNordson converts earnings into substantial cash, giving it internal funding for investment, acquisitions, debt reduction and shareholder returns. This strong conversion supports financial resilience and reduces reliance on external capital as manufacturing demand changes over the next several quarters.
Negative Factors
Meaningful absolute debtDeleveraging has improved Nordson’s balance sheet, but the remaining debt still limits financial flexibility if end-market demand weakens. Interest obligations and repayment needs can compete with acquisitions, capital investment and shareholder returns during a cyclical slowdown.

Nordson (ND1) vs. iShares MSCI Germany ETF (EWG)

-10%0%10%20%30%40%50%60%DE:ND1+48.84%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 17.97B
Dividend Yield
1.02%
Average Volume (3M)
16
Price to Earnings (P/E)
32.5
Beta (1Y)
0.53
Revenue Growth
0.77%
EPS Growth
17.13%
Country
Germany
Employees
8,200
Sector
Industrials
Sector Strength
63
Industry
Industrial - Machinery

Nordson Business Overview & Revenue Model

Company Description

Nordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, medical components, and other fluids. The Industrial Precision Solutions segment prov...

Nordson Earnings Call Summary

Earnings Call Date:Aug 18, 2026(Q3-2026)|% Change Since:11.78%|Next Earnings Date:Dec 15, 2026
Earnings Call SentimentPositive

The call was broadly positive: the company reported record sales, record EBITDA and adjusted EPS, strong free cash flow and a materially increased backlog, and it raised full-year guidance. Segment performance was strong across the board with exceptional outperformance in Advanced Technology Solutions and solid showings in Medical & Fluid Solutions. Headwinds include a noncash mark-to-market charge, ongoing inflationary pressures, a divestiture that reduced comparable medical sales, and concentration of upside in a cyclical segment (ATS) that may face tougher comparables next year. Overall financial strength (cash generation, deleveraging, margins) and constructive guidance outweighed the limited headwinds.

Positive Updates

Record Quarterly Sales
Third-quarter sales of $818 million, a 10% increase year-over-year (prior year $742 million); included 12% overall organic growth and effectively neutral currency impact.

Negative Updates

Noncash Mark-to-Market Loss Impact
Other GAAP expenses increased by $14 million year-over-year primarily due to a $15 million noncash mark-to-market charge on minority investments; management states this is market-volatility driven and negligible year-to-date.

Company Guidance

Nordson raised its fiscal 2026 full‑year guidance to $3.035–$3.075 billion in sales and $11.80–$12.00 in adjusted diluted EPS (assuming current FX rates, i.e., neutral FX), citing 35% year‑over‑year backlog growth and sustained order‑entry momentum; the update follows a record Q3 (sales $818 million, +10% YoY; organic +12%), record Q3 adjusted EPS of $3.25 (a $0.10 beat, +19% YoY), record EBITDA of $262 million (32% of sales) and adjusted operating profit of $226 million (28% of sales), with strong cash generation (Q3 free cash flow $237 million; ~144% conversion of net income), cash on hand $113 million, net debt ~$1.6 billion and leverage of 1.7x, and an expected full‑year tax rate near 18%; management cited these metrics, plus YTD capex of $40 million and year‑to‑date shareholder returns ($137 million dividends, $159 million repurchases), as the basis for the upgraded outlook.

Nordson Risk Analysis

Nordson disclosed 25 risk factors in its most recent earnings report. Nordson reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

1 New Risk
1.Changes to trade policies, tariffs, and other import/export regulations of the U.S. and other nations may create uncertainty in the global market and have a material adverse effect on our business, financial condition, and results of operations.Q2, 2025

Nordson Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

DE:ND1 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IEXIEX79Outperform$17.18B32.3913.31%1.24%6.93%14.08%
DOVDOV77Outperform$27.63B24.0715.43%1.00%8.24%-47.25%
ITTITT75Outperform$17.75B38.7710.35%0.76%28.07%-19.95%
GGGGGG74Outperform$10.82B21.4119.92%1.75%5.39%5.94%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
FLSFLS63Neutral$10.02B39.5111.35%1.10%0.21%-42.26%

* Industrials Sector Average

Performance Comparison

0%20%40%DE:ND1DOVFLSGGGIEXITTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:ND1 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:ND1Nordson Corporation290.2093.0147.16%
DOVDover Corporation207.7431.3917.80%
FLSFlowserve79.018.0011.27%
GGGGraco Inc67.44-12.86-16.02%
IEXIdex Corporation233.8467.8740.89%
ITTITT Corporation198.5014.417.83%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.